These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34512465)

  • 1. Equity Structure, Strategic Investment Psychology, and Performance in China's Green Economy Context.
    Guo LX; Lin KL; Zhang LT; Liu CF
    Front Psychol; 2021; 12():707582. PubMed ID: 34512465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do controlling shareholders' equity pledges exacerbate the stock price crash risk? -A study based on margin trading and securities lending transactions in China's securities market.
    Wang L; Cao Z; Cao W
    Heliyon; 2024 Sep; 10(18):e37473. PubMed ID: 39309845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea.
    Lee M
    Osong Public Health Res Perspect; 2015 Aug; 6(4):249-55. PubMed ID: 26473092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can fund shareholding inhibit insufficient R&D input?--Empirical evidence from Chinese listed companies.
    Li X; Liu G
    PLoS One; 2021; 16(3):e0248674. PubMed ID: 33765071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will China's R&D investment improve green innovation performance? An empirical study.
    Fan J; Teo T
    Environ Sci Pollut Res Int; 2022 Jun; 29(26):39331-39344. PubMed ID: 35099703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China's Insurance Regulatory Reform, Corporate Governance Behavior and Insurers' Governance Effectiveness.
    Li H; Zhang H; Tsai SB; Qiu A
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29039781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Largest Shareholders Incentively Affect Financial Sustainability Under Holdings Heterogeneity? Regulation/Intermediary of Financial Constraints Through Managerial Behavior Games.
    Zhang L
    Front Psychol; 2022; 13():754608. PubMed ID: 35222177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corporate governance and shareholders' confidence in cooperatives: a systematic literature review.
    Thangaveloo A; Dorasamy M; Bin Ahmad AA; Marimuthu SB; Jayabalan J
    F1000Res; 2022; 11():144. PubMed ID: 38434005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is corporate green investment a determinant of corporate carbon emission intensity? A managerial perspective.
    Zheng S; Jin S
    Heliyon; 2023 Dec; 9(12):e22401. PubMed ID: 38076108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Sustainability Narrative: A Multi Study Using Event Studies to Analyse the American Energy Companies Shareholder's Reaction to Sustainability News.
    Barroso Del Toro A; Vivas Crisol L; Tort-Martorell X
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal Control Quality, Enterprise Environmental Protection Investment and Finance Performance: An Empirical Study of China's A-Share Heavy Pollution Industry.
    Yang L; Qin H; Gan Q; Su J
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the R&D Expenditure of Listed Companies Green? Evidence from China's A-Share Market.
    Li B; Li L; Pi T
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Equity Disputes in Listed Companies With Dispersed Ownership Structure and Protection of Small and Medium Shareholders' Interests.
    He CX; Soh WN; Ong TS; Lau WT; Zhong B
    Front Psychol; 2022; 13():857585. PubMed ID: 35668972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can venture capital shareholding improve M&A performance? An empirical study based on Chinese GEM-listed companies.
    Chao K; Wang M; Hu Y; Wang S
    PLoS One; 2024; 19(8):e0308932. PubMed ID: 39146381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do institutional contingencies matter for green investment?-An institution based view of Chinese listed companies.
    Khan FU; Zhang J; Saeed I; Ullah S
    Heliyon; 2024 Jan; 10(1):e23456. PubMed ID: 38173482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Background Structure of Entrepreneurial Team and Strategic Investment Decisions: A Collective Psychological Capital Perspective.
    Guo LX; Lu KH; Cheng YF; Liu CF
    Front Psychol; 2019; 10():1416. PubMed ID: 31281285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies.
    Chen Y; Wang Y; Zhao H; Xu W
    PLoS One; 2023; 18(1):e0280237. PubMed ID: 36701361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Margin Call Pressure Affect the M&A Decision of Controlling Shareholders With Equity Pledges: Evidence From Chinese Listed Company.
    Li X; Li Q
    Front Psychol; 2022; 13():898118. PubMed ID: 35572306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institutional investors and cost of capital: The moderating effect of ownership structure.
    Huo X; Lin H; Meng Y; Woods P
    PLoS One; 2021; 16(4):e0249963. PubMed ID: 33831116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.